-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Sage Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
- Sage Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$93.6M, a 53.6% increase year-over-year.
- Sage Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$338M, a 48.5% increase year-over-year.
- Sage Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$541M, a 1.63% decline from 2022.
- Sage Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$533M, a 16.4% decline from 2021.
- Sage Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$458M, a 176% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)